Explore 3,4-CTMP | PiHKAL · info

Exploring 3,4-CTMP. To explore a different substance…

Names

3,4-CTMP
3,4-Dichloromethylphenidate
3,4-DCMP

IUPAC name

Methyl (3,4-dichlorophenyl)(piperidin-2-yl)acetate

ID 2572 · Formula C₁₄H₁₇Cl₂NO₂ · Molecular weight 302.196

InChI InChI=1S/C14H17Cl2NO2/c1-19-14(18)13(12-4-2-3-7-17-12)9-5-6-10(15)11(16)8-9/h5-6,8,12-13,17H,2-4,7H2,1H3

InChI Key JUKMAYKVHWKRKY-UHFFFAOYSA-N This stereoisomer Any stereoisomer

SMILES COC(=O)C(c1ccc(c(c1)Cl)Cl)C1CCCCN1

ChemSpider 23278471
PubChem 44418862
Wikipedia 3,4-Dichloromethylphenidate
Wikipedia, see also List of methylphenidate analogues
PsychonautWiki 3,4-CTMP
Project Response 3,4-CTMP (1100-14A)
forensicscienceeducation.org 3,4-Dichloromethylphenidate

Phenethylamine: Von der Strucktur zur Funktion 3,4-CTMP: 3.12 (55) 239

Klare, H; Neudörfl, JM; Brandt, SD; Mischler, E; Meier-Giebing, S; Deluweit, K; Westphal, F; Laussmann, T. Analysis of six “neuro-enhancing” phenidate analogs. Drug Test. Anal., 1 Mar 2017, 9 (3), 423-435. 1.4 MB. https://doi.org/10.1002/dta.2161

Luethi, D; Kaeser, PJ; Brandt, SD; Krähenbühl, S; Hoener, MC; Liechti, ME. Pharmacological profile of methylphenidate-based designer drugs. Neuropharmacology, 15 May 2018, 134 (A), 133-140. 987 kB. https://doi.org/10.1016/j.neuropharm.2017.08.020

EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.

Brandt, SD; Kavanagh, PV. Addressing the challenges in forensic drug chemistry. Drug Test. Anal., 1 Mar 2017, 9 (3), 342-346. 120 kB. https://doi.org/10.1002/dta.2169

Nichols, DE. CNS Stimulants. In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 29 Jan 2010; pp 89–120. 1.8 MB. https://doi.org/10.1002/0471266949.bmc243 #27

Luethi, D; Liechti, ME. Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics. Int. J. Neuropsychoph., 1 Oct 2018, 21 (10), 926–931. 254 kB. https://doi.org/10.1093/ijnp/pyy047 #S1 Piperidines 3,4-Dichloromethy

Carlier, J; Giorgetti, R; Varì, MR; Pirani, F; Ricci, G; Busardò, FP. Use of cognitive enhancers: methylphenidate and analogs. Eur. Rev. Med. Pharmacol. Sci., 1 Jan 2019, 23 (1), 3–15. 676 kB. https://doi.org/10.26355/eurrev_201901_16741 #3,4-CTMP

Kobayashi, M; Okamoto, K; Otake, H; Ando, T. Identification of structural analogs of methylphenidate by GC/MS. JCCL, 1 Oct 2017, (57), 75–83. 19.0 MB. #3,4-Dichloromethylphenidate Japanese, English abstract GC,MS

Uchiyama, N; Matsuda, S; Kawamura, M; Shimokawa, Y; Kikura-Hanajiri, R; Aritake, K; Urade, Y; Goda, Y. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products. Forensic Sci. Int., 1 Oct 2014, 243, 1–13. 742 kB. https://doi.org/10.1016/j.forsciint.2014.03.013 #14, 3,4-Dichloromethylphenidate GC,LC,MS,NMR,UV

Hägele, JS; Basrak, M; Schmid, MG. Enantioselective separation of novel psychoactive substances using a Lux® AMP 3 μm column and HPLC-UV. J. Pharm. Biomed. Anal., 5 Feb 2020, 179, 112967. 3.6 MB. https://doi.org/10.1016/j.jpba.2019.112967 #I1 LC

(-)-DCPCA

7 Dec 2019 · · Isomer Design